ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,3,Headache,Headaches NEC,Headaches,Nerv,N
7,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
8,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
9,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
12,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
13,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
14,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
15,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
15,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
15,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
17,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
17,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
18,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
18,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
18,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
18,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
18,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
18,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
18,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
18,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
19,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
20,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
23,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
23,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
23,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
23,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
23,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
23,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
23,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
23,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
24,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
24,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
24,3,Headache,Headaches NEC,Headaches,Nerv,N
25,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,2,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
27,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
28,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
29,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
30,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
31,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
32,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
33,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
33,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
33,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
33,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
33,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
33,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,7,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
35,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
36,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
36,2,Headache,Headaches NEC,Headaches,Nerv,N
36,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
36,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
37,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
39,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
39,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
40,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
40,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
42,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,1,Headache,Headaches NEC,Headaches,Nerv,N
43,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
43,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
44,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
44,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
45,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
45,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
46,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
46,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
47,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
48,1,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
48,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
49,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
49,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
51,2,Long QT syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
52,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
53,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
54,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
55,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
55,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
55,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
55,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
55,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
55,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
55,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
55,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
56,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
56,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
56,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
56,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
57,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
57,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
58,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
58,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
58,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,7,Headache,Headaches NEC,Headaches,Nerv,N
58,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
59,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
59,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
60,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
61,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
62,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
63,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
64,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
65,2,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
66,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
67,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
68,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
68,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
68,3,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
69,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
70,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
71,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
72,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
73,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
73,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
73,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
73,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
74,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
74,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
75,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
75,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
75,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
77,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
78,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
79,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
80,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
81,3,Headache,Headaches NEC,Headaches,Nerv,N
81,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
81,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
81,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
81,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
82,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
82,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
83,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
83,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
84,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
85,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,3,Headache,Headaches NEC,Headaches,Nerv,N
85,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
86,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
86,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
86,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,4,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
86,5,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
86,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
86,7,Migraine,Migraine headaches,Headaches,Nerv,N
86,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
86,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
86,10,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
87,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
87,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
87,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
88,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
89,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
90,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
90,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
93,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
93,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
93,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
94,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
94,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
95,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
95,3,Haematospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
96,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
96,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
96,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
97,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
98,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
100,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
100,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
100,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
101,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
102,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
102,4,Macular pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
102,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
103,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
103,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
104,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
104,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
104,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
105,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
105,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
105,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
106,1,Bone swelling,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
106,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
106,4,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
106,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
107,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
107,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
108,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
110,1,Acne,Acnes,Skin appendage conditions,Skin,N
110,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
111,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
112,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
113,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
114,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
115,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
116,1,Headache,Headaches NEC,Headaches,Nerv,N
117,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
117,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
117,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
117,4,Headache,Headaches NEC,Headaches,Nerv,N
117,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
117,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
117,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,1,Alcohol use,Alcohol product use,Lifestyle issues,SocCi,N
118,2,Alcoholism,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
118,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
118,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
118,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
119,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
119,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
120,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
120,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
120,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
122,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
122,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,3,Headache,Headaches NEC,Headaches,Nerv,N
123,1,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
123,2,Congenital pyelocaliectasis,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
123,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
123,4,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
124,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
125,1,Congenital pyelocaliectasis,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
125,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
126,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
126,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
127,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
127,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
127,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
127,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
128,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
128,3,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
128,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
128,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
128,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
129,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
130,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
131,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
131,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
131,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
131,4,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
131,5,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
131,6,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
131,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
131,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
131,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
131,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
131,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
132,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
133,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
134,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
135,1,Congenital pyelocaliectasis,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
135,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
136,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
137,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
137,2,Neurosurgery,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
138,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
138,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
138,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
138,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
139,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
141,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
142,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
143,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
143,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
144,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
144,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
145,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
145,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
145,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
145,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
145,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
145,6,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
145,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,8,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
146,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
146,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
147,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
148,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
149,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
150,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
151,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
151,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
151,3,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
151,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
152,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
153,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
153,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
153,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
153,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
153,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
154,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
154,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
154,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
154,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
154,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
155,1,Lip discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
155,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
155,3,Lipoedema,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
155,4,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
155,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
155,6,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
155,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
155,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
155,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
156,2,Headache,Headaches NEC,Headaches,Nerv,N
156,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
157,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
157,3,Headache,Headaches NEC,Headaches,Nerv,N
157,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
158,1,Headache,Headaches NEC,Headaches,Nerv,N
159,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
160,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
161,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
161,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
163,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
164,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
165,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
165,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
165,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
166,1,Breast engorgement in newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
166,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
166,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
167,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
167,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
169,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
170,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
170,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
170,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
170,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
171,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
172,1,Immobile,Disability issues,Lifestyle issues,SocCi,N
172,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Immobile,Disability issues,Lifestyle issues,SocCi,N
174,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
174,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
175,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
176,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
177,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
178,1,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
178,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
179,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
179,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
180,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
180,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
181,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
181,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
181,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
181,4,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
182,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
182,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
182,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
184,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
184,2,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
184,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
184,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
185,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
186,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
187,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
187,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,3,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
187,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
188,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
188,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
189,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
190,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
190,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
190,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
190,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
191,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
191,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
191,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
191,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
192,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
192,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
192,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
192,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
193,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
193,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
193,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
193,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
194,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
194,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
195,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
195,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
195,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
196,1,Headache,Headaches NEC,Headaches,Nerv,N
196,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
196,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
197,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
198,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,1,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
199,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
199,3,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
200,1,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,3,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
201,1,Headache,Headaches NEC,Headaches,Nerv,N
202,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
203,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
204,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
205,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
206,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
206,2,Viral load abnormal,Virus identification and serology,Microbiology and serology investigations,Inv,N
207,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
208,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
209,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
209,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
209,3,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
209,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
209,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
209,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
209,7,HLA-B*5701 assay positive,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
209,8,Headache,Headaches NEC,Headaches,Nerv,N
209,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
209,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
209,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
209,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,13,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
209,14,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
209,15,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
209,16,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
209,17,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,18,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
209,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
211,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
212,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
213,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
214,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
215,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
215,2,Headache,Headaches NEC,Headaches,Nerv,N
215,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
216,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
217,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
217,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
217,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
219,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
219,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
219,3,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
220,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
221,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
222,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
222,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
222,3,Menopause,Age related issues,Age related factors,SocCi,N
223,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
223,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
224,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
224,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
225,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
227,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
227,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
227,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
228,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,2,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
228,3,Tenoplasty,Tendon therapeutic procedures,Soft tissue therapeutic procedures,Surg,N
229,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
230,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
231,1,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
232,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
232,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
233,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
233,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
234,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
235,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
236,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
237,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
237,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
237,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
237,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
237,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
238,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
239,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
240,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
241,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
242,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
243,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
244,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
244,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
246,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
246,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
246,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
246,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
246,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
246,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,7,Vertical infection transmission,Infectious transmissions,Ancillary infectious topics,Infec,N
246,8,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
247,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
248,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
248,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
248,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
250,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
251,1,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
252,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
252,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
253,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
253,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
254,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
255,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
255,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
256,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
256,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
257,2,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
258,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
258,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
258,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
259,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
259,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
259,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
260,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
261,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
262,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
263,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
265,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
265,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
265,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
266,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
267,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
268,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
269,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
270,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
270,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
270,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
270,4,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
271,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
271,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
271,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
272,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
273,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
273,2,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
273,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
275,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
275,2,Product use in unapproved therapeutic environment,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
275,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
276,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
276,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
276,3,Product use in unapproved therapeutic environment,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
276,4,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
277,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
278,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
278,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
279,2,Disease risk factor,Social issues NEC,Lifestyle issues,SocCi,N
279,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
280,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
281,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
282,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
283,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
283,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
285,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
286,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
287,1,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
287,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
287,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
287,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
288,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
289,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
290,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
291,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
291,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
292,1,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
293,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
293,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
293,3,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
294,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
294,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
295,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
295,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
295,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
296,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
296,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
297,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
297,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
297,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
298,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
298,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
299,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
300,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
301,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
301,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
301,3,Splenic vein thrombosis,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
302,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
302,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
302,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
303,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
304,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
304,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
305,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
306,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
307,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
308,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
308,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
309,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
309,2,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
309,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
310,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
311,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
312,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
312,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
312,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
312,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
313,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
314,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
315,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
316,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
316,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
317,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
317,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
317,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
318,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
319,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
320,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
321,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
321,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
321,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
321,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
321,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
322,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
322,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
322,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
325,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
325,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
325,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
325,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
326,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
327,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
328,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
328,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
328,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
328,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
328,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
328,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
328,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
329,1,Lymphoma AIDS related,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
329,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
330,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
331,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
332,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
333,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
334,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
334,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
335,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
335,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
336,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
337,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
338,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
338,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
338,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
339,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
339,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
340,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
340,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
341,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
342,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
342,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
343,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
344,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
345,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
346,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
346,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
347,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
347,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
347,3,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
347,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
348,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
348,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
349,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
350,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
351,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,2,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
351,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
352,1,Disease risk factor,Social issues NEC,Lifestyle issues,SocCi,N
353,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
354,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
354,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
355,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
356,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
357,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
357,3,Headache,Headaches NEC,Headaches,Nerv,N
357,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
358,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
359,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
360,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
361,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
361,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
362,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
363,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
364,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
364,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
365,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
366,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
366,2,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
366,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
366,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
366,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
367,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
368,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
369,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
370,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
371,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
372,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
373,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
374,1,Product use in unapproved therapeutic environment,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
374,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
375,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
376,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
376,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
377,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
